In a recent study of induced sputum samples from 330 participants, no significant difference in sputum ACE2 positivity was observed between patients with asthma and healthy subjects [24], which implies that the risk of COVID-19 may not be increased among patients with asthma. The gene discussed is ACE2; the disease is COVID-19.